Yüklüyor......
Special considerations for proprietary name review: focus on products that may be prescribed “as directed”
BACKGROUND: Look-alike and sound-alike (LASA) drug name similarity is often cited as a major factor contributing to wrong drug errors. When present on a prescription, differing product characteristics or directions for use may help healthcare professionals differentiate between two LASA drug names....
Kaydedildi:
| Yayımlandı: | Ther Innov Regul Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037609/ https://ncbi.nlm.nih.gov/pubmed/29929377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479018782669 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|